R&D Systems™ Recombinant Influenza A Virus H3N2 Hemagglutinin Protein

Description

His-tag

Measured by its binding ability in a functional ELISA. When Recombinant Human Galectin-1 (Catalog # 1152-GA ) immobilized at 10.00 μg/mL, 100 μL/well, the concentration of Recombinant Influenza A Virus H3N2 Hemagglutinin His-tag (Catalog # 10944-HA) that produces 50% of the optimal binding response is 0.35-3.50 μg/mL.

Specifications

• Accession Number: Q91MA7.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Molecular Weight (g/mol): MolecularWeight-observed: 80-90 kDa, under reducing conditions., MolecularWeight-theroretical: 58 kDa
• Quantity: 100 μg
• Source: Human embryonic kidney cell, HEK293-derived influenza a virus h3n2 Hemagglutinin protein Gln17-Trp530, with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <1.0 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 100 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: Hemagglutinin/HA Peptide